The administration of nonmetabolizable glucose analogues fails to suppress the development of glycogen autophagy in newborn rat hepatocytes
| Autor: | Stefanos A. Kalamidas, D.J. Kondomerkos |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Blood Glucose
Photomicrography medicine.medical_specialty Histology Liver cytology Carbohydrate metabolism Deoxyglucose Xylitol chemistry.chemical_compound Internal medicine medicine Autophagy Animals Rats Wistar Glycogen synthase Instrumentation Microscopy biology Glycogen Histocytochemistry Glucose analog Propranolol Rats Medical Laboratory Technology Endocrinology Glucose chemistry Animals Newborn Liver Vacuoles biology.protein Acid alpha-glucosidase Hepatocytes 3-O-Methylglucose Anatomy Glucan 1 4-alpha-Glucosidase |
| Zdroj: | Microscopy research and technique. 73(11) |
| ISSN: | 1097-0029 |
| Popis: | The effects of parenteral administration of glucose, 3-methylglucose (3MG), or 2-deoxyglucose (2DG) on the glycogen autophagy were studied in the newborn rat liver using electron microscopy and biochemical methods. The administration of glucose resulted in hyperglycemia and prevented the mobilization of hepatocytic glycogen. It also prevented the development of autophagic vacuoles in general and inhibited the glycogen-degrading activity of acid α-1,4-glucosidase. The nonphosphorylated and not further metabolized glucose analog 3MG also produced hyperglycemia, but increased acid glucosidase. Pretreating the newborns with the β-adrenergic blocker propranolol inhibited the effects of 3MG. The phosphorylated but not fully metabolized glucose analog 2DG produced similar effects. The administration of xylitol to the newborns already treated with 2DG, suppressed acid glucosidase. The results of this and our previous studies suggest that glucose must be metabolized beyond its phosphorylation step to inhibit acid glucosidase activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text